"Wir diagnostizieren, beraten und behandeln Patienten mit onkologischen und hämatologischen Erkrankungen. Darüberhinaus sind wir auch hausärztlich tätig. Ihre Ansprechpartner: Dr. med. Richard Schabath Dr. med. Stephan Fuhrmann Janina Herbin Dr. med. Christian Sperling Prof. Dr. med. Wolf-Dieter Ludwig"

During the past decade, Onkologische Schwerpunktpraxis conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Onkologische Schwerpunktpraxis" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials, followed by "Daiichi Sankyo, Inc." with 1 trials sponsored, "German CLL Study Group" with 1 trials sponsored, "Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH" with 1 trials sponsored and "Heidelberg University" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onkologische Schwerpunktpraxis" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "ClinAssess GmbH" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "Spanish Breast Cancer Research Group (SOLTI)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Onkologische Schwerpunktpraxis" are "Leukemia" (2 trials), "Lymphoma" (2 trials), "Breast Cancer" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Colorectal Carcinoma" (1 trials). Many other conditions were trialed in "Onkologische Schwerpunktpraxis" in a lesser frequency.

Most popular intervention types in "Onkologische Schwerpunktpraxis" are "Drug" (9 trials), "Biological" (4 trials), "Radiation" (3 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (3 trials), "radiation therapy" (3 trials), "allogeneic bone marrow transplantation" (2 trials), "cytarabine" (2 trials) and "doxorubicin hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Onkologische Schwerpunktpraxis" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Onkologische Schwerpunktpraxis". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Onkologische Schwerpunktpraxis, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Onkologische Schwerpunktpraxis, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".